Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

Item

http://www.wikidata.org/entity/Q39543940

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

@en

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

@nl

type

Item

label

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

@en

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

@nl

prefLabel

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

@en

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

@nl

P1476

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

@en

P2093

F Schwenter

http://www.w3.org/2001/XMLSchema#string

J S Lee

http://www.w3.org/2001/XMLSchema#string

N Bouche

http://www.w3.org/2001/XMLSchema#string

N Mach

http://www.w3.org/2001/XMLSchema#string

P Luy

http://www.w3.org/2001/XMLSchema#string

P Morel

http://www.w3.org/2001/XMLSchema#string

R C Mulligan

http://www.w3.org/2001/XMLSchema#string

S Zarei

http://www.w3.org/2001/XMLSchema#string

V Padrun

http://www.w3.org/2001/XMLSchema#string

P2860

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

K562--a human erythroleukemic cell line

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique.

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.

A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.

A GM-CSF/CD40L producing cell augments anti-tumor T cell responses.

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

P2888

cgt.2011.22

P304

553-562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2011.22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21566667

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy